Jan Mattsson

Insider Reports History

Entity
Individual
Location
C/O Albireo Pharma, Inc., 50 Milk Street, 16 Th Floor, Boston, MA
Signature
/s/ Jason Duncan, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jan Mattsson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALBIREO PHARMA, INC. Chief Scientific Officer Common Stock 0 $43.80 Mar 2, 2023 Direct
ALBIREO PHARMA, INC. Chief Scientific Officer Restricted Stock Units 0 Mar 2, 2023 Direct
ALBIREO PHARMA, INC. Chief Scientific Officer Stock Option (Right to Buy) 0 Mar 2, 2023 Direct

Insider Reports Filed by Jan Mattsson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALBO ALBIREO PHARMA, INC. Mar 2, 2023 8 $0 4 Mar 2, 2023 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Jan 23, 2023 1 -$8.63K 4 Jan 23, 2023 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Jan 19, 2023 1 $0 4/A Jan 27, 2023 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Jan 19, 2023 1 -$135K 4 Jan 20, 2023 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Oct 24, 2022 1 -$3.95K 4 Oct 25, 2022 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Jul 22, 2022 1 -$5.06K 4 Jul 25, 2022 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Apr 22, 2022 1 -$6.58K 4 Apr 25, 2022 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Jan 24, 2022 1 -$20.1K 4 Jan 25, 2022 Chief Scientific Officer
ALBO ALBIREO PHARMA, INC. Jan 18, 2022 1 $0 4 Jan 20, 2022 Chief Scientific Officer